Long-acting 2 agonists as potential option in the treatment of acute exacerbations of COPD

Author： Cazzola M.   Matera M.G.  

Publisher： Elsevier

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.16, Iss.4, 2003-07, pp. : 197-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting -Agonists in the Treatment of Acute Exacerbations of COPD

By Cazzola M.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 369-376

Adis International

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

By Maria Gabriella Matera  

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 503-515

Adis International

Access to resources Recommend Favorite

Long-acting β2 agonists

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite